anti glp 1 antibody Anti-GLP-1 [24H1L3] Cited in 1 publication Anti-GLP-1 antibody [EPR4042-407] (ab111125) |

According to NICE guidance, GLP-1 receptor agonists for type 2 diabetes (NG28) are recommended when other treatments have not achieved adequate glycaemic control

Photochem Photobiol Sci

The lack of immunogenicity has practical implications: the peptide can be used for extended periods without loss of efficacy due to antibody neutralization, there is minimal risk of allergic or hypersensitivity reactions, and repeated treatment cycles are supported as prior exposure does not sensitize the immune system

No more blind spots from members going off- benefit

This change in ion concentration may then trigger a series of events that result in the cell taking action, such as releasing enzymes or producing new proteins